InvestorsHub Logo
Followers 91
Posts 7427
Boards Moderated 1
Alias Born 06/17/2008

Re: None

Monday, 02/03/2020 11:59:27 AM

Monday, February 03, 2020 11:59:27 AM

Post# of 127
Jumped in today at $3.

Only bought 3K shares but it is slowly moving up and garnering strength. Will continue to acquire on dips. IBC is a common problem. I know. I have suffered from it. And, anything that can relieve pain from cancers is a winner.

The Company is developing ART12.11 for targeting the development in Inflammatory Bowel Disease (IBD), stroke and rare/orphan diseases. ART26.12 is its endocannabinoid transport protein (FABP5) inhibitor for treatment of breast cancer, prostate cancer, and neuropathic and nociceptive pain.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARTL News